Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

Fig. 4

Radiological reactions, incidence of FN and other adverse reactions. RP: Radiation pneumonia, RE: Radiation esophagitis, FN: Febrile neutropenia. * Factors with statistical significance: ns: no significance; *: p < 0.05; **: p < 0.01; ***: p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us